Author | Mark Lowery, Editor


Sandoz to offer generic Solaraze

November 22, 2013

Sandoz has announced the U.S. launch of an authorized generic version of PharmaDerm’s Solaraze Gel (diclofenac 3% gel), which generated $92 million in 2012.

New compounding rules won’t prevent another tragedy, AMCP says

November 21, 2013

Congressional action to tighten regulations for compounding pharmacies will not prevent another tragedy such as last year’s fungal meningitis outbreak, according to the Academy of Managed Care Pharmacy.

Pharmacist wins age discrimination case against CVS

November 21, 2013

After celebrating his 65th birthday at the beach, pharmacist Roger Harris returned to his Anniston, Ala. workplace to find a surprise waiting for him: He had been fired and replaced by a 27 year-old.

New outcomes data to be included on Xeljanz labels

November 19, 2013

FDA has approved the supplemental New Drug Application for tofacitinib citrate (Xeljanz, Pfizer) to include additional patient-reported outcomes data on the label.